Panorama français des habitudes d’injection de toxine botulique dans ses indications neurologiques

Tsui JosephKC, 1986, Double-blind study of botulinum toxin in spasmodic torticollis, Lancet, 328, 245, 10.1016/S0140-6736(86)92070-2 Stell, 1988, Botulinum toxin in spasmodic torticollis, J Neurol Neurosurg Psychiatr, 51, 920, 10.1136/jnnp.51.7.920 Benecke, 2005, A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia, Neurology, 64, 1949, 10.1212/01.WNL.0000163767.99354.C3 Dodick, 2010, OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program, Headache: J Head Face Pain, 50, 921, 10.1111/j.1526-4610.2010.01678.x Jost, 2019, SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea, Neurology, 92, e1982, 10.1212/WNL.0000000000007368 Grigoriu, 2015, Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review, Arch Phys Med Rehabil, 96, 2067, 10.1016/j.apmr.2015.05.002 Schramm, 2015, Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement, J Neural Transm (Vienna), 122, 1457, 10.1007/s00702-014-1356-2 Wu, 2022, Response rates of online surveys in published research:a meta-analysis, Computers in Human Behavior Reports, 7, 100206, 10.1016/j.chbr.2022.100206